ADAMTS9 and ADAMTS20 are differentially affected by loss of B3GLCT in mouse model of Peters plus syndrome. (10th October 2019)

• Record Type: Journal Article
• Authors: Holdener, Bernadette C; Percival, Christopher J; Grady, Richard C; Cameron, Daniel C; Berardinelli, Steven J; Zhang, Ao; Neupane, Sanjiv; Takeuchi, Megumi; Jimenez-Vega, Javier C; Uddin, Sardar M Z; Komatsu, David E; Honkanen, Robert; Dubail, Johanne; Apte, Suneel S; Sato, Takashi; Narimatsu, Hisashi; McClain, Steve A; Haltiwanger, Robert S
• Is Part Of: Human molecular genetics. Volume 28:Number 24(2019)
• Page Start: 4053
• Page End: 4066
• Publication Date: 2019-10-10
• Subjects: Human molecular genetics -- Periodicals; Human chromosome abnormalities -- Periodicals; 572.8
• DOI: 10.1093/hmg/ddz225
• Languages: English
• ISSNs: 0964-6906

Abstract

Abstract: Peters plus syndrome (MIM #261540 PTRPLS), characterized by defects in eye development, prominent forehead, hypertelorism, short stature and brachydactyly, is caused by mutations in the β 3-glucosyltransferase ( B3GLCT ) gene. Protein O- fucosyltransferase 2 (POFUT2) and B3GLCT work sequentially to add an O- linked glucose β 1-3fucose disaccharide to properly folded thrombospondin type 1 repeats (TSRs). Forty-nine proteins are predicted to be modified by POFUT2, and nearly half are members of the ADAMTS superfamily. Previous studies suggested that O- linked fucose is essential for folding and secretion of POFUT2-modified proteins and that B3GLCT-mediated extension to the disaccharide is essential for only a subset of targets. To test this hypothesis and gain insight into the origin of PTRPLS developmental defects, we developed and characterized two mouse B3glct knockout alleles. Using these models, we tested the role of B3GLCT in enabling function of ADAMTS9 and ADAMTS20, two highly conserved targets whose functions are well characterized in mouse development. The mouse B3glct mutants developed craniofacial and skeletal abnormalities comparable to PTRPLS. In addition, we observed highly penetrant hydrocephalus, white spotting and soft tissue syndactyly. We provide strong genetic and biochemical evidence that hydrocephalus and white spotting in B3glct mutants resulted from loss of ADAMTS20, eye abnormalities from partial reduction of ADAMTS9 and cleft palate from loss of ADAMTS20 and partially reduced ADAMTS9 function. Combined, these results provide compelling evidence that ADAMTS9 and ADAMTS20 were differentially sensitive to B3GLCT inactivation and suggest that the developmental defects in PTRPLS result from disruption of a subset of highly sensitive POFUT2/B3GLCT targets such as ADAMTS20.